280 related articles for article (PubMed ID: 17074918)
1. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review.
Johnson SR; Mehta S; Granton JT
Eur Respir J; 2006 Nov; 28(5):999-1004. PubMed ID: 17074918
[TBL] [Abstract][Full Text] [Related]
2. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW
Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis.
Caldeira D; Loureiro MJ; Costa J; Pinto FJ; Ferreira JJ
Can J Cardiol; 2014 Aug; 30(8):879-87. PubMed ID: 24986048
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension.
Johnson SR; Granton JT; Mehta S
Chest; 2006 Aug; 130(2):545-52. PubMed ID: 16899857
[TBL] [Abstract][Full Text] [Related]
5. [Anticoagulation therapy in pulmonary arterial hypertension].
Akagi S; Kusano KF
Nihon Rinsho; 2008 Nov; 66(11):2174-8. PubMed ID: 19051739
[TBL] [Abstract][Full Text] [Related]
6. [Anticoagulation in pulmonary arterial hypertension].
Grünig E; Ehlken N; Nagel Ch
Hamostaseologie; 2008 Oct; 28(4):225-30. PubMed ID: 18836649
[TBL] [Abstract][Full Text] [Related]
7. A descriptive evaluation of warfarin use in patients with pulmonary arterial hypertension.
Irwin AN; Johnson SG; Joline BR; Delate T; Witt DM
Thromb Res; 2014 May; 133(5):790-4. PubMed ID: 24642007
[TBL] [Abstract][Full Text] [Related]
8. Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.
Calderone A; Stevens W; Prior D; Nandurkar H; Gabbay E; Proudman SM; Williams T; Celermajer D; Sahhar J; Wong PK; Thakkar V; Dwyer N; Wrobel J; Chin W; Liew D; Staples M; Buchbinder R; Nikpour M
BMJ Open; 2016 Dec; 6(12):e011028. PubMed ID: 27932335
[TBL] [Abstract][Full Text] [Related]
9. Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?
Khan MS; Usman MS; Siddiqi TJ; Khan SU; Murad MH; Mookadam F; Figueredo VM; Krasuski RA; Benza RL; Rich JD
Circ Cardiovasc Qual Outcomes; 2018 Sep; 11(9):e004757. PubMed ID: 30354550
[TBL] [Abstract][Full Text] [Related]
10. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease.
Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Le T; Lee P; Seary ME; Hawker GA; Feldman BM
J Rheumatol; 2012 Feb; 39(2):276-85. PubMed ID: 22247353
[TBL] [Abstract][Full Text] [Related]
11. Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?
Nikpour M; Stevens W; Proudman SM; Buchbinder R; Prior D; Zochling J; Williams T; Gabbay E; Nandurkar H
Intern Med J; 2013 May; 43(5):599-603. PubMed ID: 23668273
[TBL] [Abstract][Full Text] [Related]
12. Whither Anticoagulation in Pulmonary Arterial Hypertension? Conflicting Evidence REVEALed.
Frantz RP
Circulation; 2015 Dec; 132(25):2360-2. PubMed ID: 26510695
[No Abstract] [Full Text] [Related]
13. Effect of warfarin on survival in scleroderma-associated pulmonary arterial hypertension (SSc-PAH) and idiopathic PAH. Belief elicitation for Bayesian priors.
Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Hawker GA; Feldman BM
J Rheumatol; 2011 Mar; 38(3):462-9. PubMed ID: 21159827
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the quality of anticoagulation management in patients with pulmonary arterial hypertension.
Roldan T; Villamañán E; Rios JJ; Waxman AB
Thromb Res; 2017 Dec; 160():83-90. PubMed ID: 29127864
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation in Pulmonary Arterial Hypertension.
Robinson JC; Pugliese SC; Fox DL; Badesch DB
Curr Hypertens Rep; 2016 Jun; 18(6):47. PubMed ID: 27137522
[TBL] [Abstract][Full Text] [Related]
16. Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertension.
Jansa P; Hrachovinova I; Ambroz D; Maresova J; Polacek P; Simkova I; Linhart A; Aschermann M
Bratisl Lek Listy; 2010; 111(11):595-8. PubMed ID: 21384745
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer?
Rawal H; Suman A; Bhoite RR; Kanwal A; Young RK; Aronow WS; Lavie C; Ghosh RK
Curr Probl Cardiol; 2021 Mar; 46(3):100738. PubMed ID: 33250263
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge.
Roldan T; Landzberg MJ; Deicicchi DJ; Atay JK; Waxman AB
J Heart Lung Transplant; 2016 Feb; 35(2):151-64. PubMed ID: 26527532
[TBL] [Abstract][Full Text] [Related]
20. Changing the prognosis of pulmonary arterial hypertension: impact of medical therapy.
Chakinala MM
Semin Respir Crit Care Med; 2005 Aug; 26(4):409-16. PubMed ID: 16121318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
